Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cheewadhanaraks S et al. - At months 3, 6, 9, 12 and 15 of the treatment phase, there was no statistically significant difference of percentages of patients with satisfaction between the two regimens. The optimal interval of injections of depot medroxyprogesterone acetate 150 mg is every 3 months.

Today in Clinical Pharmacology...keeping you current

Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09

The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09

Factors contributing to gender differences in serum retinol and -tocopherol in infertile couples
Reproductive BioMedicine Online, 11/24/09

Today in General Gynecology...keeping you current

Perianal Endometriosis Mimicking Recurrent Perianal Abscess
Case Reports in Gastroenterology, 11/25/09

Patients report on how endometriosis affects health, work, and daily life
Fertility and Sterility, 11/24/09

Quality of reporting of randomized controlled trials in polycystic ovary syndrome
Trials, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address